Projects

This section presents pharmaceutical projects that are announced from time-to-time around the world.

Cellares to Construct New Smart Factory in New Jersey, USA

Cellares plans to construct the first commercialscale smart factory in New Jersey, USA

McCord Development Invests US$30 million to Open BioHub in Texas, USA

McCord Development makes a investment of US$30 million to significantly expand its biomanufacturing capabilities with the establishment of BioHub Two

Astellas Pharma Set to Unveil State-of-the-Art Life Sciences Facility in Massachusetts, USA

Astellas Pharma opens a new stateoftheart life sciences facility to expand its RD footprint in order to accelerate innovation and deliver VALUE to patients

Croda Commences Construction of New Manufacturing Facility in Pennsylvania, USA

Croda plans for the construction of stateoftheart facility dedicated to pharmaceutical excipients manufacturing

Fusion Pharmaceuticals to Open Radiopharmaceutical Manufacturing Facility in Canada

The new facility will create more than 100,000 doses of these targeted alpha therapies every year This stateoftheart facility is designed with the capacity to engage in both clinical and commercial scale manufacturing

GenScript Doubles Manufacturing Capacity for cGMP sgRNA and Non-Viral DNA Payloads in Jiangsu, China

GenScript enhances cGMP Manufacturing Capacity for sgRNA and NonViral DNA Payloads capacity The facility will be loacted in Jiangsu, China

Vertex and Lonza Plan to Build Manufacturing Facility in New Hampshire, USA

Vertex and Lonza plan to open a new facility to support the manufacturing of type 1 diabetes T1D cell therapies

Cincinnati Children's Hospital Invests US$42 million to Open Research Pavilion in Avondale, USA

Cincinnati Children invests US$42 million to open new research pavilion The site will become new home for several critical facilities, including the vaccine research center, a biobank, and a freezer archive

Kindeva to Invest US$42 million(£33m) to Enhance Inhaler Manufacturing in UK

Kindeva reveives an investment support of US$42 million33m from the UK government to enhanc inhaler manufacturing and sustainability

Oxford Properties Group Invests US$91 million for GMP Facility in USA

Oxford Properties Group sells stateoftheart GMP facility in Marlborough,USA for US$91 million to Moderna